Relx Plc $RELX Shares Acquired by Coldstream Capital Management Inc.

Coldstream Capital Management Inc. boosted its position in Relx Plc (NYSE:RELX) by 133.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,371 shares of the technology company’s stock after buying an additional 17,934 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Relx were worth $1,705,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in RELX. ABC Arbitrage SA increased its holdings in shares of Relx by 188.9% in the 2nd quarter. ABC Arbitrage SA now owns 560,958 shares of the technology company’s stock valued at $30,482,000 after acquiring an additional 366,761 shares during the last quarter. Ameriprise Financial Inc. boosted its holdings in Relx by 8.3% in the first quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company’s stock worth $154,129,000 after purchasing an additional 234,094 shares during the period. Connor Clark & Lunn Investment Management Ltd. increased its stake in Relx by 103.4% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 444,360 shares of the technology company’s stock valued at $22,400,000 after purchasing an additional 225,947 shares during the last quarter. Evelyn Partners Asset Management Ltd acquired a new stake in shares of Relx during the second quarter worth $11,649,000. Finally, Northern Trust Corp raised its holdings in shares of Relx by 9.2% during the first quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company’s stock worth $120,686,000 after purchasing an additional 202,509 shares during the period. Institutional investors and hedge funds own 15.02% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on RELX. Weiss Ratings lowered shares of Relx from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, November 19th. Kepler Capital Markets upgraded Relx from a “hold” rating to a “strong-buy” rating in a research note on Thursday, September 18th. Barclays reaffirmed an “overweight” rating on shares of Relx in a report on Tuesday, October 7th. Wall Street Zen cut Relx from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Finally, Morgan Stanley restated an “overweight” rating on shares of Relx in a research report on Thursday, September 11th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy”.

Relx Trading Down 0.7%

Shares of Relx stock opened at $40.32 on Tuesday. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55. Relx Plc has a 1-year low of $39.31 and a 1-year high of $56.33. The business’s fifty day moving average price is $44.72 and its two-hundred day moving average price is $49.11.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.